Over the last 15 years, Dr. David has co-founded four technology companies that have together raised more than $1.5 billion in financing and currently employ over 400 scientists, engineers, and business people. Dr. David builds companies as a means to create technologies that change the world. Dr. David is a co-founder of Syrrx (acquired by Takeda), Achaogen (NASDAQ: AKAO), Kythera Biopharmaceuticals (NASDAQ: KYTH), and Sapphire Energy. He holds pending and issued patents in fields such as nanovolume crystallography, antibiotic resistance, and aesthetic medicine.
Dr. David has served on the board of directors of Kythera Biopharmaceuticals and Sapphire Energy and is a member of the board of trustees of the University of California Foundation and the Buck Institute for Research on Aging. He was named one of the Top 100 innovators in the world under 35 by the MIT Technology Review.
Dr. David holds a Ph.D. from the University of California, Berkeley in Molecular and Cellular Biology and an A.B. in Biology from Harvard University.